New gel injection aims to dissolve unsightly lumps without surgery
NCT ID NCT07237425
Summary
This early-stage study is testing a new injectable drug called Ronkyla Plus for treating superficial lipomas, which are common, non-cancerous fatty lumps under the skin. The goal is to see if it is safe, how the body processes it, and if it can shrink or clear these lumps, potentially offering a non-surgical option. The study will enroll 56 healthy adults and compare the new injection to an existing approved treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBMENTAL FULLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cathay General Hospital
RECRUITINGTaipei, Da'an District, 106436, Taiwan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Cathay General Hospital Sijhih Branch
RECRUITINGNew Taipei City, Sijhih District, 22174, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.